Many studies have reported PLK1 as a critical driver in HCC and overexpressed PLK1 promotes cell growth during hepatocarcinogenesis, indicating that PLK1 is a promising therapeutic target for HCC 3, 26-28. Here, PLK1 is linked to hepatocellular carcinoma.